Commission on the House of Reformation and Instruction for Colored Children - Establishment
HB0552 requires every institution of higher education in Maryland to provide drug detection products to students at no charge. The bill defines a drug detection product as a disposable test product that can be used to check a drug for the presence of fentanyl. Institutions must make these products available in student health centers, libraries, and bathrooms, creating a broad campus distribution requirement intended to increase student access.
The bill also updates an existing annual reporting requirement for institutions of higher education. Each institution must report to the appropriate commission both incidents requiring naloxone or other overdose-reversing medication and the quantity of drug detection products distributed. The act takes effect July 1, 2025, and amends Maryland Education Article provisions related to drug abuse policies and prevention.
HB0552 expands the responsibilities of Maryland institutions of higher education by mandating free access to fentanyl test strips or similar drug detection products and by requiring campus placement in multiple public-facing locations. It also broadens reporting obligations by adding distribution data to existing overdose-related incident reporting, which may increase administrative tracking and state oversight of campus harm-reduction efforts. The bill amends the Education Article’s drug abuse prevention subtitle and affects colleges and universities statewide.
The available context suggests the bill is generally supportive and likely aimed at harm reduction and overdose prevention, with no recorded committee debate or vote opposition in the provided materials. The broad sponsorship list and the unanimous Senate passage with amendments indicate substantial legislative support. Overall, the measure appears to have been treated as a public health and student safety initiative rather than a controversial policy change.
No committee transcript is provided, so specific objections are not documented in the supplied record. Potential points of contention inherent in the bill include whether colleges should be required to distribute drug detection products at no charge, where those products should be placed on campus, and whether the reporting mandate adds administrative burden. Any disagreement would likely center on the balance between harm-reduction access, institutional costs, and concerns about normalizing drug use, but those views are not explicitly reflected in the available materials.